X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | PRVB | Sessa Capital (Master), L.P. | 10% | S - Sale+OE | $24.32 | -2,190,549 | 15,994,428 | -12% | -$53,274,152 | |||||
| DM | 2023-02-10 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.09 | -75,985 | 2,573,000 | -3% | -$766,549 | |||||
2023-02-10 | PRVB | Hoitt Jason | Chief Commercial Officer | S - Sale | $10.00 | -4,500 | 0 | -100% | -$45,005 | ||||||
| DM | 2023-02-10 | PRVB | Palmer Ashleigh | Dir, CEO | S - Sale+OE | $10.09 | -75,835 | 2,570,050 | -3% | -$765,003 | |||||
| D | 2023-01-18 | PRVB | Palmer Ashleigh | Dir, CEO | S - Sale+OE | $10.27 | -24,165 | 2,570,050 | -1% | -$248,063 | |||||
| D | 2023-01-18 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.27 | -24,015 | 2,573,000 | -1% | -$246,584 | |||||
2023-01-18 | PRVB | Sessa Capital (Master), L.P. | 10% | S - Sale | $9.40 | -3,000,000 | 11,879,023 | -20% | -$28,200,000 | ||||||
| D | 2022-12-29 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.26 | -187,000 | 2,573,000 | -7% | -$1,918,601 | |||||
| D | 2022-12-27 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.00 | -10,674 | 2,573,000 | 0% | -$106,740 | |||||
| DM | 2022-12-22 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.00 | -1,943 | 2,573,000 | 0% | -$19,431 | |||||
2021-12-03 | PRVB | Ramos Eleanor | Chief Medical Officer | P - Purchase | $6.49 | +5,201 | 70,000 | +8% | +$33,765 | ||||||
2021-11-30 | PRVB | Palmer Ashleigh | Dir, CEO | P - Purchase | $6.66 | +3,750 | 2,570,050 | 0% | +$24,990 | ||||||
2021-11-24 | PRVB | Leon Francisco | Chief Scientific Officer | P - Purchase | $7.24 | +5,550 | 2,573,000 | 0% | +$40,188 | ||||||
2020-09-02 | PRVB | Ramos Eleanor | Chief Medical Officer | P - Purchase | $12.06 | +299 | 64,799 | 0% | +$3,606 | ||||||
2020-09-02 | PRVB | Drechsler Andrew T | CFO | P - Purchase | $11.72 | +2,000 | 20,000 | +11% | +$23,440 | ||||||
2020-08-21 | PRVB | Leon Francisco | Chief Scientific Officer | P - Purchase | $13.35 | +2,000 | 2,567,450 | 0% | +$26,708 | ||||||
2020-08-20 | PRVB | Ramos Eleanor | Chief Medical Officer | P - Purchase | $13.23 | +2,500 | 64,500 | +4% | +$33,075 | ||||||
2020-08-18 | PRVB | Palmer Ashleigh | Pres, CEO | P - Purchase | $12.69 | +500 | 2,566,300 | 0% | +$6,345 | ||||||
2020-08-17 | PRVB | Palmer Ashleigh | Pres, CEO | P - Purchase | $12.83 | +2,800 | 2,565,800 | 0% | +$35,924 | ||||||
2020-08-13 | PRVB | Drechsler Andrew T | CFO | P - Purchase | $13.01 | +1,750 | 18,000 | +11% | +$22,768 | ||||||
2020-06-24 | PRVB | Leon Francisco | Chief Scientific Officer | P - Purchase | $15.43 | +2,000 | 2,565,450 | 0% | +$30,862 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |